Bladder cancer.
作者信息
van der Meijden A P
机构信息
Department of Urology, Bosch Medicentrum, PO Box 90153, 5200 ME 's-Hertogenbosch, Netherlands.
出版信息
BMJ. 1998 Nov 14;317(7169):1366-9. doi: 10.1136/bmj.317.7169.1366.
Abstract
摘要
相似文献
1
Bladder cancer.膀胱癌
BMJ. 1998 Nov 14;317(7169):1366-9. doi: 10.1136/bmj.317.7169.1366.
2
[Diagnosis and therapy of bladder cancer].
MMW Fortschr Med. 2015 Nov 19;157(20):42-5. doi: 10.1007/s15006-015-7539-4.
3
[Bladder cancer--symptoms and diagnosis].[膀胱癌——症状与诊断]
MMW Fortschr Med. 2011 Aug 11;153(32-34):38-41; quiz 42.
4
Urinary bladder cancer.膀胱癌
Clin Obstet Gynecol. 2002 Sep;45(3):844-54. doi: 10.1097/00003081-200209000-00031.
5
The management of bladder cancer--a case history.膀胱癌的治疗——病例报告
Ann Oncol. 1993 Apr;4(4):325-9. doi: 10.1093/oxfordjournals.annonc.a058493.
6
Bladder cancer in women.女性膀胱癌
Int Urogynecol J Pelvic Floor Dysfunct. 1999;10(6):399-404. doi: 10.1007/s001920050068.
7
Bladder cancer: revealing news about a hidden threat.膀胱癌：揭示关于一种隐藏威胁的新消息。
Nursing. 2006 Apr;36(4):54-7. doi: 10.1097/00152193-200604000-00041.
8
Hematuria screening for bladder cancer.膀胱癌的血尿筛查。
J Occup Med. 1990 Sep;32(9):838-45. doi: 10.1097/00043764-199009000-00016.
9
[Current status of diagnosis and therapy of bladder carcinoma].[膀胱癌的诊断与治疗现状]
Z Arztl Fortbild (Jena). 1982 Sep 15;76(18):815-21.
10
Small-cell carcinoma of the urinary bladder: diagnosis and management.膀胱小细胞癌：诊断与管理
Expert Rev Anticancer Ther. 2006 Dec;6(12):1707-13. doi: 10.1586/14737140.6.12.1707.
引用本文的文献
1
Targeting and Internalization of Liposomes by Bladder Tumor Cells Using a Fibronectin Attachment Protein-Derived Peptide-Lipopolymer Conjugate.使用纤连蛋白附着蛋白衍生肽-脂聚合物偶联物实现膀胱肿瘤细胞对脂质体的靶向与内化
Bioconjug Chem. 2017 May 17;28(5):1481-1490. doi: 10.1021/acs.bioconjchem.7b00153. Epub 2017 May 5.
2
Activation of Hedgehog signaling by the environmental toxicant arsenic may contribute to the etiology of arsenic-induced tumors.环境毒物砷激活 Hedgehog 信号通路可能导致砷诱导肿瘤的发生。
Cancer Res. 2010 Mar 1;70(5):1981-8. doi: 10.1158/0008-5472.CAN-09-2898. Epub 2010 Feb 23.
3
The association between personal habits and bladder cancer in Turkey.土耳其个人习惯与膀胱癌之间的关联。
Int Urol Nephrol. 2008;40(3):643-7. doi: 10.1007/s11255-008-9331-1. Epub 2008 Feb 5.
4
Hexyl aminolevulinate: in the detection of bladder cancer.己基氨基乙酰丙酸：用于膀胱癌检测
Drugs. 2006;66(4):571-8; discussion 579-80. doi: 10.2165/00003495-200666040-00010.
5
The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review.吸烟、饮料消费、饮食与膀胱癌之间的关联：一项系统的文献综述。
World J Urol. 2004 Feb;21(6):392-401. doi: 10.1007/s00345-003-0382-8. Epub 2003 Dec 17.
6
Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer.c-myc和CCND1基因畸变在浸润性膀胱癌发生发展中的作用
Br J Cancer. 2002 Sep 9;87(6):654-8. doi: 10.1038/sj.bjc.6600531.
7
Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.11号和17号染色体杂合性缺失是膀胱移行细胞癌复发的标志物。
Br J Cancer. 2001 Dec 14;85(12):1894-9. doi: 10.1054/bjoc.2001.2159.
8
Are retinol, vitamin C, vitamin E, folate and carotenoids intake associated with bladder cancer risk? Results from the Netherlands Cohort Study.视黄醇、维生素C、维生素E、叶酸和类胡萝卜素的摄入量与膀胱癌风险有关吗？荷兰队列研究的结果。
Br J Cancer. 2001 Sep 28;85(7):977-83. doi: 10.1054/bjoc.2001.1968.
9
Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model.猿猴病毒40 T抗原转基因小鼠模型中的高侵袭性膀胱移行细胞癌
Am J Pathol. 2000 Sep;157(3):805-13. doi: 10.1016/S0002-9440(10)64594-4.
10
Review on bladder cancer. New rather than old TNM staging system should have been used.膀胱癌综述。本应采用新的而非旧的TNM分期系统。
BMJ. 1999 Mar 27;318(7187):875-6. doi: 10.1136/bmj.318.7187.875a.
本文引用的文献
1
A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer.欧洲癌症研究与治疗组织及医学研究理事会针对TaT1期膀胱癌预防性治疗的随机临床试验联合分析。欧洲癌症研究与治疗组织泌尿生殖系统癌症合作组及医学研究理事会浅表膀胱癌工作组。
J Urol. 1996 Dec;156(6):1934-40, discussion 1940-1.
2
Use of a new tumor marker, urinary NMP22, in the detection of occult or rapidly recurring transitional cell carcinoma of the urinary tract following surgical treatment.一种新型肿瘤标志物——尿NMP22在手术治疗后隐匿性或快速复发的泌尿道移行细胞癌检测中的应用。
J Urol. 1996 Aug;156(2 Pt 1):363-7. doi: 10.1097/00005392-199608000-00008.
3
The ileal neobladder: 6 years of experience with more than 200 patients.回肠新膀胱：200 多名患者的 6 年经验。
J Urol. 1993 Jul;150(1):40-5. doi: 10.1016/s0022-5347(17)35392-2.
4
Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder cancer.一项使用BTA检测来监测和诊断复发性膀胱癌的多中心试验结果。
J Urol. 1995 Aug;154(2 Pt 1):379-83; discussion 383-4. doi: 10.1097/00005392-199508000-00013.
5
Neoadjuvant and adjuvant chemotherapy in advanced disease--what are the effects on survival and prognosis?
Int J Urol. 1995 Jun;2 Suppl 2:76-88. doi: 10.1111/j.1442-2042.1995.tb00482.x.
6
The status of bladder-preserving therapeutic strategies in the management of patients with muscle-invasive bladder cancer.保膀胱治疗策略在肌层浸润性膀胱癌患者管理中的地位。
Int J Urol. 1995 Jun;2 Suppl 2:49-57. doi: 10.1111/j.1442-2042.1995.tb00479.x.
7
The place of radiation therapy as definitive treatment of bladder cancer.放射治疗作为膀胱癌确定性治疗方法的地位。
Int J Urol. 1995 Jun;2 Suppl 2:41-8. doi: 10.1111/j.1442-2042.1995.tb00478.x.
8
Management of invasive bladder neoplasms.浸润性膀胱肿瘤的管理
Semin Urol. 1983 Feb;1(1):34-41.
9
Bladder cancer in relation to cigarette smoking.膀胱癌与吸烟的关系。
Cancer Res. 1988 Aug 1;48(15):4405-8.
10
An overview of intravesical therapy for superficial bladder tumors.
J Urol. 1987 Dec;138(6):1363-8. doi: 10.1016/s0022-5347(17)43644-5.
Zotero 插件